Cite
Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer
MLA
Lin Jing, et al. “Targeting the Up-Regulated CNOT3 Reverses Therapeutic Resistance and Metastatic Progression of EGFR-Mutant Non-Small Cell Lung Cancer.” Cell Death Discovery, vol. 9, no. 1, Nov. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41420-023-01701-w.
APA
Lin Jing, Meng-En Zhai, Mei-Rui Qian, Yi-Ming Li, Ming-Wei Han, Kun Wang, Wan Huang, Gang Nan, & Jian-Li Jiang. (2023). Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer. Cell Death Discovery, 9(1), 1–12. https://doi.org/10.1038/s41420-023-01701-w
Chicago
Lin Jing, Meng-En Zhai, Mei-Rui Qian, Yi-Ming Li, Ming-Wei Han, Kun Wang, Wan Huang, Gang Nan, and Jian-Li Jiang. 2023. “Targeting the Up-Regulated CNOT3 Reverses Therapeutic Resistance and Metastatic Progression of EGFR-Mutant Non-Small Cell Lung Cancer.” Cell Death Discovery 9 (1): 1–12. doi:10.1038/s41420-023-01701-w.